Condition

Gastroenteropancreatic Neuroendocrine Tumor clinical trials and research

• 8Clinical trials
• 6Countries

Newest Gastroenteropancreatic Neuroendocrine Tumor clinical trials

All recruiting trials (8)

• GEP-NET treatment patterns and outcomes in the U.S.

  This study will see how newly diagnosed GEP-NET patients are treated in real-world settings and what their outcomes look like.

  Recruiting Novartis · East Hanover, New Jersey · NCT07635316

• Nutritional status monitoring for adults with gastroenteropancreatic neuroendocrine tumors

  This project will see if nutrition problems are common and linked to outcomes in adults aged 18–70 being followed for gastroenteropancreatic neuroendocrine tumors at Strasbourg University Hospital.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07302100

• RYZ401 for solid tumors that express somatostatin receptors

  This trial will try RYZ401, a targeted radiotherapy, in adults with neuroendocrine or other solid tumors that show somatostatin receptors to find a safe dose and see if it shrinks tumors.

  Recruiting at 15 sites Phase 1 RayzeBio, Inc. · Phoenix, Arizona and 14 other locations · NCT07165132

• Characterizing Gastroenteropancreatic Neuroendocrine Tumors Treated With Targeted Radionuclide Therapy

  This study is trying to see if advanced imaging can help doctors choose the right patients for a specific cancer treatment for gastroenteropancreatic neuroendocrine tumors to improve their chances of success.

  Recruiting at 3 sites Assistance Publique - Hôpitaux de Paris · Clichy and 4 other locations · NCT06256705

• Using 68Ga-DOTATOC PET to evaluate gastroenteropancreatic neuroendocrine tumors

  This study is testing if a special type of PET scan can help doctors better diagnose gastroenteropancreatic neuroendocrine tumors in adults.

  Recruiting IRCCS San Raffaele · Milan · NCT06155318

• Continuing somatostatin analogues for patients with advanced neuroendocrine tumors

  This study is testing whether continuing somatostatin therapy helps people with advanced neuroendocrine tumors do better after their initial treatment compared to stopping the therapy when they start a new treatment.

  Recruiting at 9 sites Phase 4 University Hospital, Antwerp · Brasschaat, Antwerp and 18 other locations · NCT05701241

• Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

  This study is testing a new type of treatment using targeted alpha-particle therapy to see if it can help people with advanced neuroendocrine tumors that have a specific protein called SSTR2.

  Recruiting at 20 sites Phase 1/2 Perspective Therapeutics · Jacksonville, Florida and 19 other locations · NCT05636618

• Peptide receptor radionuclide therapy for gastroenteropancreatic neuroendocrine tumors

  This study will collect information to see how well peptide receptor radionuclide therapy (PRRT) works and how safe it is for adults with gastroenteropancreatic neuroendocrine tumors.

  Recruiting Methodist Health System · Dallas, Texas and 1 other locations · NCT04090034

Related topics

Quick answers

How many Gastroenteropancreatic Neuroendocrine Tumor clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (4 trials), France (2 trials), Belgium (1 trial), Netherlands (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →